BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11511919)

  • 1. Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases.
    Smith WM; Zhou XP; Kurose K; Gao X; Latif F; Kroll T; Sugano K; Cannistra SA; Clinton SK; Maher ER; Prior TW; Eng C
    Hum Genet; 2001 Aug; 109(2):146-51. PubMed ID: 11511919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population.
    Zhou XP; Smith WM; Gimm O; Mueller E; Gao X; Sarraf P; Prior TW; Plass C; von Deimling A; Black PM; Yates AJ; Eng C
    J Med Genet; 2000 Jun; 37(6):410-4. PubMed ID: 10851250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
    Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
    J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity.
    Evans D; Mann WA; de Heer J; Michel U; Wendt D; Kortner B; Wolf A; Beisiegel U
    Int J Obes Relat Metab Disord; 2000 May; 24(5):647-51. PubMed ID: 10849589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
    Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.
    Ikezoe T; Miller CW; Kawano S; Heaney A; Williamson EA; Hisatake J; Green E; Hofmann W; Taguchi H; Koeffler HP
    Cancer Res; 2001 Jul; 61(13):5307-10. PubMed ID: 11431375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
    Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
    Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.
    Tomita S; Kawamata H; Imura J; Omotehara F; Ueda Y; Fujimori T
    Int J Mol Med; 2002 May; 9(5):485-8. PubMed ID: 11956653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.
    Martelli ML; Iuliano R; Le Pera I; Sama' I; Monaco C; Cammarota S; Kroll T; Chiariotti L; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4728-35. PubMed ID: 12364466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the E-cadherin gene in human gynecologic cancers.
    Risinger JI; Berchuck A; Kohler MF; Boyd J
    Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
    Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
    Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
    Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.
    Ridker PM; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Plutzky J; Zee RY
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):859-63. PubMed ID: 12663371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
    Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
    Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
    Kroll TG; Sarraf P; Pecciarini L; Chen CJ; Mueller E; Spiegelman BM; Fletcher JA
    Science; 2000 Aug; 289(5483):1357-60. PubMed ID: 10958784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Birt-Hogg-DubĂ© (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
    da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
    J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
    Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
    J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.
    Landi S; Moreno V; Gioia-Patricola L; Guino E; Navarro M; de Oca J; Capella G; Canzian F;
    Cancer Res; 2003 Jul; 63(13):3560-6. PubMed ID: 12839942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.